CVAC begins to look increasingly bullish having broke above the downtrend.
Volume does remain low though.
Bullish moving average cross imminent
Indicators in bullish trajectory.
Potential entry above $59.00 at Fibonacci resistance.
Target $64-$66
CVAC has staged a 25% reversal off the IPO lows and may offer a nice opportunity in the coming days
as its rise may attract some more attention.
Major targets are=
1) $59.00 & $63.99 Fibonacci retracement level.
Crossing the POC (redline) @ $57.52 would be bullish.
Often, we take up a trade without spending even 1 minute of our time asking the reasons why. I am guilty of that and have paid my tuition fees back to the market.
So, Curevac is backed by Bill Gates of Microsoft and traders start to get imaginative and think the share price is going to rocket up.
Maybe, it will but it is also highly speculative. And is this...
Paper in the range. The position is accumulating or there are no strong buyers or sellers yet, this can be seen on the Hourly chart. Waiting for the end of consolidation or trading on the trend from the resistance. The short trend from resistance is a more appropriate strategy here in my opinion.
My analysis/assumption for that stock.
Please give your rating if...
The $300 Million grant from the EU may have not
resulted in the rally that was expected on Friday.
Potential short term targets as per Horizontal resistance levels
& Fibonacci levels $70 is a key level for Bulls to reclaim.
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
After a huge runup CVAC found a bottom on 0.382 level but made a lower high bouncing around 0.786 fib level and 0.382 fib level making a double bot on that 0.382 fib level. The momentum right now is very bullish and if the previous lower high just above 0.618 fib level is broken it will very likely continue its uptrend after retesting that lower high and breaking...
CureVac Expected to Receive up to 252 million Euros from the German Federal Ministry of Research for Further COVID-19 Vaccine Development and Production Capacity Expansion
In July 2020, CureVac had applied to a grant as part of a special program to accelerate the research and development of urgently needed vaccines against SARS-CoV-2. On July 29, the Federal...
CureVac Stock Jumps on News of EU Talks to Supply Covid-19
CureVac and European Commission in Advanced Discussions to Supply up to 405 million doses of potential mRNA-based COVID-19 Vaccine
in talks to sell 225 million doses of its experimental Covid-19 vaccine to the European Commission.
In a statement Thursday, CureVac said it had “concluded exploratory talks...
Stock gapped up today as a result of a sizeable contract from the EU.
Technically the stock found support on the Fibonacci Golden Pocket (.65-.618).
Was somewhat surprising that there was no follow through in the afternoon session,
but lets see will tomorrow bring more gains.
7&12 moving averages support and holding above the VWAP
PLEASE GIVE US A LIKE IF YOU...
CVAC had a $16 IPO entry price and peaked at $65 today. This shows why I love IPOs for stocks that enter into the market. This also proves why I hate many traditional broker accounts. Lots of traditional broker accounts don't give you access to the early level IPO price for the first hours the stock hits the market, and this is one of the most annoying things in...
